Sun Pharma Advanced Research Company to conduct AGM,
Sun Pharma Advanced Research Company announced that the 19th Annual General Meeting (AGM) of the company will be held on 12 August 2024.Powered by Capital Market - Live News
Sun Pharma Advanced Research Company reports consolidated net loss of Rs 105.79 crore in the March 2024 quarter,
Net Loss of Sun Pharma Advanced Research Company reported to Rs 105.79 crore in the quarter ended March 2024 as against net loss of Rs 81.99 crore during the previous quarter ended March 2023. Sales declined 65.28% to Rs 16.56 crore in the quarter ended March 2024 as against Rs 47.69 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 387.21 crore in the year ended March 2024 as against net loss of Rs 222.58 crore during the previous year ended March 2023. Sales declined 68.36% to Rs 75.55 crore in the year ended March 2024 as against Rs 238.78 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales16.5647.69 -65 75.55238.78 -68 OPM %-639.07-187.82 --532.23-89.65 - PBDT-102.34-79.05 -29 -374.32-210.81 -78 PBT-105.41-81.99 -29 -386.83-222.58 -74 NP-105.79-81.99 -29 -387.21-222.58 -74 Powered by Capital Market - Live News
Sun Pharma Advanced Research Company reports standalone net loss of Rs 99.65 crore in the December 2023 quarter,
Net loss of Sun Pharma Advanced Research Company reported to Rs 99.65 crore in the quarter ended December 2023 as against net profit of Rs 10.15 crore during the previous quarter ended December 2022. Sales declined 89.43% to Rs 13.86 crore in the quarter ended December 2023 as against Rs 131.09 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales13.86131.09 -89 OPM %-740.4012.34 - PBDT-96.4913.28 PL PBT-99.6510.15 PL NP-99.6510.15 PL Powered by Capital Market - Live News
Sun Pharma Advanced Research Company schedules board meeting,
Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the Company on 5 February 2024.Powered by Capital Market - Live News
Sun Pharma Advanced Research Company reports standalone net loss of Rs 86.42 crore in the September 2023 quarter,
Net Loss of Sun Pharma Advanced Research Company reported to Rs 86.42 crore in the quarter ended September 2023 as against net loss of Rs 68.40 crore during the previous quarter ended September 2022. Sales declined 32.85% to Rs 21.18 crore in the quarter ended September 2023 as against Rs 31.54 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales21.1831.54 -33 OPM %-431.87-198.48 - PBDT-83.24-65.40 -27 PBT-86.42-68.40 -26 NP-86.42-68.40 -26 Powered by Capital Market - Live News
Subscribe for our
newsletter
Open Account Now